752
Views
16
CrossRef citations to date
0
Altmetric
Research Paper

Effectiveness of an Indian-made Attenuated influenza A(H1N1)pdm 2009 vaccine

A case control study

, , , , , , , , & show all
Pages 566-571 | Received 08 Nov 2013, Accepted 11 Dec 2013, Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Irina Isakova-Sivak, Elena Grigorieva & Larisa Rudenko. (2020) Insights into current clinical research on the immunogenicity of live attenuated influenza vaccines. Expert Review of Vaccines 19:1, pages 43-55.
Read now
Irina Isakova-Sivak & Larisa Rudenko. (2015) Safety, immunogenicity and infectivity of new live attenuated influenza vaccines. Expert Review of Vaccines 14:10, pages 1313-1329.
Read now
Irina Isakova-Sivak, Marina Stukova, Mariana Erofeeva, Anatoly Naykhin, Svetlana Donina, Galina Petukhova, Victoria Kuznetsova, Irina Kiseleva, Tatiana Smolonogina, Irina Dubrovina, Maria Pisareva, Alexandra Nikiforova, Maureen Power, Jorge Flores & Larisa Rudenko. (2015) H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers. Human Vaccines & Immunotherapeutics 11:4, pages 970-982.
Read now
Larisa Rudenko & Irina Isakova-Sivak. (2015) Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus. Expert Review of Vaccines 14:3, pages 395-412.
Read now

Articles from other publishers (12)

Robert K. M. Choy, A. Louis Bourgeois, Christian F. Ockenhouse, Richard I. Walker, Rebecca L. Sheets & Jorge Flores. (2022) Controlled Human Infection Models To Accelerate Vaccine Development. Clinical Microbiology Reviews 35:3.
Crossref
Kanta Subbarao. (2021) Live Attenuated Cold-Adapted Influenza Vaccines. Cold Spring Harbor Perspectives in Medicine 11:9, pages a038653.
Crossref
Yashwant Kumar Ratre, Naveen Kumar Vishvakarma, L. V. K. S. Bhaskar & Henu Kumar Verma. (2020) Dynamic Propagation and Impact of Pandemic Influenza A (2009 H1N1) in Children: A Detailed Review. Current Microbiology 77:12, pages 3809-3820.
Crossref
Huiying Chua, Shuo Feng, Joseph A. Lewnard, Sheena G. Sullivan, Christopher C. Blyth, Marc Lipsitch & Benjamin J. Cowling. (2020) The Use of Test-negative Controls to Monitor Vaccine Effectiveness. Epidemiology 31:1, pages 43-64.
Crossref
Kristen D C Lewis, Justin R Ortiz, Mohammed Z Rahman, Min Z Levine, Larisa Rudenko, Peter F Wright, Jacqueline M Katz, Len Dally, Mustafizur Rahman, Irina Isakova-Sivak, Natalia A Ilyushina, Victoria Matyushenko, Alicia M Fry, Stephen E Lindstrom, Joseph S Bresee, W Abdullah Brooks & Kathleen M Neuzil. (2019) Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh. Clinical Infectious Diseases 69:5, pages 777-785.
Crossref
Svetlana Shcherbik, Nicholas Pearce, Paul Carney, Ekaterina Bazhenova, Natalie Larionova, Irina Kiseleva, Larisa Rudenko, Amrita Kumar, Cynthia S. Goldsmith, Vivien Dugan, James Stevens, David E. Wentworth & Tatiana Bousse. (2019) Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells. Vaccine: X 2, pages 100031.
Crossref
Leena R. Yeolekar, Milan Ganguly, Parikshit Tyagi, Nilesh B. Ingle, Koert J. Stittelaar, Leon de Waal, Francesco Berlanda Scorza, Kutub Mahmood & Rajeev M. Dhere. (2018) Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains. Vaccine 36:46, pages 6944-6952.
Crossref
Prashant V. Nigwekar, Anuj Kumar, Vikram V. Padbidri, Amlan Choudhury, Amol B. Chaudhari & Prasad S. Kulkarni. (2017) Safety of Russian-Backbone Trivalent, Live Attenuated Seasonal Influenza Vaccine in Healthy Subjects: Open-Label, Non-randomized Phase 4 Study. Drug Safety 41:2, pages 171-177.
Crossref
Victoria Matyushenko, Irina Isakova-Sivak, Tatiana Smolonogina, Irina Dubrovina, Tatiana Tretiak & Larisa Rudenko. (2017) Genotyping assay for differentiation of wild-type and vaccine viruses in subjects immunized with live attenuated influenza vaccine. PLOS ONE 12:7, pages e0180497.
Crossref
Louise E. Lansbury, Sherie Smith, Walter Beyer, Emina Karamehic, Eva Pasic-Juhas, Hana Sikira, Ana Mateus, Hitoshi Oshitani, Hongxin Zhao, Charles R. Beck & Jonathan S. Nguyen-Van-Tam. (2017) Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis. Vaccine 35:16, pages 1996-2006.
Crossref
John C Victor, Kristen D C Lewis, Aldiouma Diallo, Mbayame N Niang, Bou Diarra, Ndongo Dia, Justin R Ortiz, Marc-Alain Widdowson, Jodi Feser, Rebecca Hoagland, Shannon L Emery, Kathryn E Lafond & Kathleen M Neuzil. (2016) Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial. The Lancet Global Health 4:12, pages e955-e965.
Crossref
Larisa Rudenko, Leena Yeolekar, Irina Kiseleva & Irina Isakova-Sivak. (2016) Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories. Vaccine 34:45, pages 5436-5441.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.